Clinical Trial Watch: Mayo Clinic to Study Scibase’s Non-invasive Skin Cancer Diagnostic Technology
The Mayo Clinic is conducting a pilot study of Scibase’s Nevisense. Nevisense is a point-of-care platform that combines artificial intelligence and advanced Electrical Impedance Spectroscopy (EIS) technology to help dermatologists differentiate challenging benign pigmented lesions from melanomas. EIS uses harmless electrical signals to measure the electrical impedance of the skin at different frequencies. “Melanoma is […]